ZYNTEGLO is manufactured and delivered through a highly coordinated and regulated process that involves close collaboration with the referring physician, the ZYNTEGLO Qualified Treatment Centre, and bluebird bio

ZYNTEGLO Qualified Treatment Centres

• If you are considering a patient for ZYNTEGLO, contact a ZYNTEGLO Qualified Treatment Centre to discuss eligibility and next steps
• ZYNTEGLO is specifically manufactured for each individual patient because it uses the patient’s own HSCs

Qualified Treatment Centres Have Been Carefully Assessed for:

• Mission alignment with gene therapy
• Optimised patient access
• Clinical care capabilities
• Gene therapy manufacturing

Please continue to check back for updates as Qualified Treatment Centres are added.